Clinical Trial Update: Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure [Phase 1]

View source ↗

Summary

This clinical trial update notes the completion of a Phase I study of Alpha-Melanocyte Stimulating Hormone in patients with Acute Renal Failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Failure

Drugs mentioned

• Alpha-Melanocyte Stimulating Hormone (alpha-Melanocyte Stimulating Hormone)

Snippet

Sponsor: University of Texas | Conditions: Acute Renal Failure | Phase 1 | Status: COMPLETED